Gilead Sciences to Present at Upcoming Second Quarter 2026 Investor Conferences

Key Terms

covid-19 medical

COVID-19 is an infectious disease caused by the SARS‑CoV‑2 virus that can produce symptoms from mild respiratory illness to severe, life‑threatening complications. It matters to investors because outbreaks, containment measures, vaccination campaigns and treatments change consumer behavior, supply chains, labor availability and healthcare demand—like a sudden storm that reroutes traffic—altering company revenues, costs and overall market risk.

hiv medical

Human immunodeficiency virus (HIV) is a virus that gradually damages the body's infection-fighting system and can lead to serious illness if not treated. For investors, HIV matters because progress or setbacks in tests, treatments, or vaccines can change demand for medicines, affect regulatory approvals and patent value, and shift healthcare spending—similar to how a major technology breakthrough can reshape an entire industry’s market prospects.

viral hepatitis medical

Viral hepatitis is an infection of the liver caused by specific viruses that inflame and damage the organ, like a clog in an engine that reduces performance. It matters to investors because its prevalence and severity drive demand for diagnostics, treatments, and vaccines, influence healthcare costs and regulatory attention, and can materially affect the prospects and valuations of companies working on therapies or public-health responses.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:

• BofA Securities Health Care Conference on Tuesday, May 12 at 2:20 PM Pacific Time
• RBC Capital Markets Global Healthcare Conference on Tuesday, May 19 at 11:00 AM Eastern Time
• Bernstein Annual Strategic Decisions Conference on Thursday, May 28 at 11:00 AM Eastern Time
• Goldman Sachs Annual Global Healthcare Conference on Tuesday, June 9 at 1:20 PM Eastern Time

The live webcasts can be accessed at the company’s investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation.

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260501262300/en/

Jacquie Ross, CFA – Investors
investor_relations@gilead.com

Source: Gilead Sciences, Inc.